Copyright Reports & Markets. All rights reserved.

Global Solid Formulations Drug Delivery Market Report, History and Forecast 2017-2028, Breakdown Data by Companies, Key Regions, Types and Application

Buy now

1 Market Overview of Solid Formulations Drug Delivery

  • 1.1 Solid Formulations Drug Delivery Market Overview
  • 1.1.1 Solid Formulations Drug Delivery Product Scope
  • 1.1.2 Solid Formulations Drug Delivery Market Status and Outlook
  • 1.2 Global Solid Formulations Drug Delivery Market Size Overview by Region 2017 VS 2021 VS 2028
  • 1.3 Global Solid Formulations Drug Delivery Market Size by Region (2017-2028)
  • 1.4 Global Solid Formulations Drug Delivery Historic Market Size by Region (2017-2022)
  • 1.5 Global Solid Formulations Drug Delivery Market Size Forecast by Region (2023-2028)
  • 1.6 Key Regions, Solid Formulations Drug Delivery Market Size (2017-2028)
  • 1.6.1 North America Solid Formulations Drug Delivery Market Size (2017-2028)
  • 1.6.2 Europe Solid Formulations Drug Delivery Market Size (2017-2028)
  • 1.6.3 Asia-Pacific Solid Formulations Drug Delivery Market Size (2017-2028)
  • 1.6.4 Latin America Solid Formulations Drug Delivery Market Size (2017-2028)
  • 1.6.5 Middle East & Africa Solid Formulations Drug Delivery Market Size (2017-2028)
  • 2 Solid Formulations Drug Delivery Market Overview by Type

    • 2.1 Global Solid Formulations Drug Delivery Market Size by Type: 2017 VS 2021 VS 2028
    • 2.2 Global Solid Formulations Drug Delivery Historic Market Size by Type (2017-2022)
    • 2.3 Global Solid Formulations Drug Delivery Forecasted Market Size by Type (2023-2028)
    • 2.4 Powders
    • 2.5 Suppositories

    3 Solid Formulations Drug Delivery Market Overview by Application

    • 3.1 Global Solid Formulations Drug Delivery Market Size by Application: 2017 VS 2021 VS 2028
    • 3.2 Global Solid Formulations Drug Delivery Historic Market Size by Application (2017-2022)
    • 3.3 Global Solid Formulations Drug Delivery Forecasted Market Size by Application (2023-2028)
    • 3.4 Home Care Settings
    • 3.5 Hospitals & Clinics
    • 3.6 Burn Centers
    • 3.7 Other Facilities

    4 Solid Formulations Drug Delivery Competition Analysis by Players

    • 4.1 Global Solid Formulations Drug Delivery Market Size by Players (2017-2022)
    • 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Solid Formulations Drug Delivery as of 2021)
    • 4.3 Date of Key Players Enter into Solid Formulations Drug Delivery Market
    • 4.4 Global Top Players Solid Formulations Drug Delivery Headquarters and Area Served
    • 4.5 Key Players Solid Formulations Drug Delivery Product Solution and Service
    • 4.6 Competitive Status
    • 4.6.1 Solid Formulations Drug Delivery Market Concentration Rate
  • 4.6.2 Mergers & Acquisitions, Expansion Plans
  • 5 Company (Top Players) Profiles and Key Data

    • 5.1 Pfizer
    • 5.1.1 Pfizer Profile
  • 5.1.2 Pfizer Main Business
  • 5.1.3 Pfizer Solid Formulations Drug Delivery Products, Services and Solutions
  • 5.1.4 Pfizer Solid Formulations Drug Delivery Revenue (US$ Million) & (2017-2022)
  • 5.1.5 Pfizer Recent Developments
  • 5.2 Teva Pharmaceuticals
  • 5.2.1 Teva Pharmaceuticals Profile
  • 5.2.2 Teva Pharmaceuticals Main Business
  • 5.2.3 Teva Pharmaceuticals Solid Formulations Drug Delivery Products, Services and Solutions
  • 5.2.4 Teva Pharmaceuticals Solid Formulations Drug Delivery Revenue (US$ Million) & (2017-2022)
  • 5.2.5 Teva Pharmaceuticals Recent Developments
  • 5.3 Bristol Myers Squibb
  • 5.3.1 Bristol Myers Squibb Profile
  • 5.3.2 Bristol Myers Squibb Main Business
  • 5.3.3 Bristol Myers Squibb Solid Formulations Drug Delivery Products, Services and Solutions
  • 5.3.4 Bristol Myers Squibb Solid Formulations Drug Delivery Revenue (US$ Million) & (2017-2022)
  • 5.3.5 Lead Chemical Recent Developments
  • 5.4 Lead Chemical
  • 5.4.1 Lead Chemical Profile
  • 5.4.2 Lead Chemical Main Business
  • 5.4.3 Lead Chemical Solid Formulations Drug Delivery Products, Services and Solutions
  • 5.4.4 Lead Chemical Solid Formulations Drug Delivery Revenue (US$ Million) & (2017-2022)
  • 5.4.5 Lead Chemical Recent Developments
  • 5.5 Purdue Pharma
  • 5.5.1 Purdue Pharma Profile
  • 5.5.2 Purdue Pharma Main Business
  • 5.5.3 Purdue Pharma Solid Formulations Drug Delivery Products, Services and Solutions
  • 5.5.4 Purdue Pharma Solid Formulations Drug Delivery Revenue (US$ Million) & (2017-2022)
  • 5.5.5 Purdue Pharma Recent Developments
  • 5.6 Glenmark Pharmaceuticals
  • 5.6.1 Glenmark Pharmaceuticals Profile
  • 5.6.2 Glenmark Pharmaceuticals Main Business
  • 5.6.3 Glenmark Pharmaceuticals Solid Formulations Drug Delivery Products, Services and Solutions
  • 5.6.4 Glenmark Pharmaceuticals Solid Formulations Drug Delivery Revenue (US$ Million) & (2017-2022)
  • 5.6.5 Glenmark Pharmaceuticals Recent Developments
  • 5.7 Galderma
  • 5.7.1 Galderma Profile
  • 5.7.2 Galderma Main Business
  • 5.7.3 Galderma Solid Formulations Drug Delivery Products, Services and Solutions
  • 5.7.4 Galderma Solid Formulations Drug Delivery Revenue (US$ Million) & (2017-2022)
  • 5.7.5 Galderma Recent Developments
  • 5.8 Johnson & Johnson Private
  • 5.8.1 Johnson & Johnson Private Profile
  • 5.8.2 Johnson & Johnson Private Main Business
  • 5.8.3 Johnson & Johnson Private Solid Formulations Drug Delivery Products, Services and Solutions
  • 5.8.4 Johnson & Johnson Private Solid Formulations Drug Delivery Revenue (US$ Million) & (2017-2022)
  • 5.8.5 Johnson & Johnson Private Recent Developments
  • 5.9 GlaxoSmithKline
  • 5.9.1 GlaxoSmithKline Profile
  • 5.9.2 GlaxoSmithKline Main Business
  • 5.9.3 GlaxoSmithKline Solid Formulations Drug Delivery Products, Services and Solutions
  • 5.9.4 GlaxoSmithKline Solid Formulations Drug Delivery Revenue (US$ Million) & (2017-2022)
  • 5.9.5 GlaxoSmithKline Recent Developments
  • 5.10 Bausch Health Companies
  • 5.10.1 Bausch Health Companies Profile
  • 5.10.2 Bausch Health Companies Main Business
  • 5.10.3 Bausch Health Companies Solid Formulations Drug Delivery Products, Services and Solutions
  • 5.10.4 Bausch Health Companies Solid Formulations Drug Delivery Revenue (US$ Million) & (2017-2022)
  • 5.10.5 Bausch Health Companies Recent Developments
  • 5.11 Hisamitsu Pharmaceuticals
  • 5.11.1 Hisamitsu Pharmaceuticals Profile
  • 5.11.2 Hisamitsu Pharmaceuticals Main Business
  • 5.11.3 Hisamitsu Pharmaceuticals Solid Formulations Drug Delivery Products, Services and Solutions
  • 5.11.4 Hisamitsu Pharmaceuticals Solid Formulations Drug Delivery Revenue (US$ Million) & (2017-2022)
  • 5.11.5 Hisamitsu Pharmaceuticals Recent Developments
  • 5.12 Cipla
  • 5.12.1 Cipla Profile
  • 5.12.2 Cipla Main Business
  • 5.12.3 Cipla Solid Formulations Drug Delivery Products, Services and Solutions
  • 5.12.4 Cipla Solid Formulations Drug Delivery Revenue (US$ Million) & (2017-2022)
  • 5.12.5 Cipla Recent Developments
  • 5.13 Bayer
  • 5.13.1 Bayer Profile
  • 5.13.2 Bayer Main Business
  • 5.13.3 Bayer Solid Formulations Drug Delivery Products, Services and Solutions
  • 5.13.4 Bayer Solid Formulations Drug Delivery Revenue (US$ Million) & (2017-2022)
  • 5.13.5 Bayer Recent Developments
  • 5.14 Viatris
  • 5.14.1 Viatris Profile
  • 5.14.2 Viatris Main Business
  • 5.14.3 Viatris Solid Formulations Drug Delivery Products, Services and Solutions
  • 5.14.4 Viatris Solid Formulations Drug Delivery Revenue (US$ Million) & (2017-2022)
  • 5.14.5 Viatris Recent Developments
  • 5.15 3M
  • 5.15.1 3M Profile
  • 5.15.2 3M Main Business
  • 5.15.3 3M Solid Formulations Drug Delivery Products, Services and Solutions
  • 5.15.4 3M Solid Formulations Drug Delivery Revenue (US$ Million) & (2017-2022)
  • 5.15.5 3M Recent Developments
  • 5.16 Merck & Co
  • 5.16.1 Merck & Co Profile
  • 5.16.2 Merck & Co Main Business
  • 5.16.3 Merck & Co Solid Formulations Drug Delivery Products, Services and Solutions
  • 5.16.4 Merck & Co Solid Formulations Drug Delivery Revenue (US$ Million) & (2017-2022)
  • 5.16.5 Merck & Co Recent Developments
  • 5.17 Crescita Therpeautics
  • 5.17.1 Crescita Therpeautics Profile
  • 5.17.2 Crescita Therpeautics Main Business
  • 5.17.3 Crescita Therpeautics Solid Formulations Drug Delivery Products, Services and Solutions
  • 5.17.4 Crescita Therpeautics Solid Formulations Drug Delivery Revenue (US$ Million) & (2017-2022)
  • 5.17.5 Crescita Therpeautics Recent Developments
  • 5.18 Novartis International
  • 5.18.1 Novartis International Profile
  • 5.18.2 Novartis International Main Business
  • 5.18.3 Novartis International Solid Formulations Drug Delivery Products, Services and Solutions
  • 5.18.4 Novartis International Solid Formulations Drug Delivery Revenue (US$ Million) & (2017-2022)
  • 5.18.5 Novartis International Recent Developments
  • 5.19 Boehringer Ingelheim
  • 5.19.1 Boehringer Ingelheim Profile
  • 5.19.2 Boehringer Ingelheim Main Business
  • 5.19.3 Boehringer Ingelheim Solid Formulations Drug Delivery Products, Services and Solutions
  • 5.19.4 Boehringer Ingelheim Solid Formulations Drug Delivery Revenue (US$ Million) & (2017-2022)
  • 5.19.5 Boehringer Ingelheim Recent Developments
  • 6 North America

    • 6.1 North America Solid Formulations Drug Delivery Market Size by Country (2017-2028)
    • 6.2 United States
    • 6.3 Canada

    7 Europe

    • 7.1 Europe Solid Formulations Drug Delivery Market Size by Country (2017-2028)
    • 7.2 Germany
    • 7.3 France
    • 7.4 U.K.
    • 7.5 Italy
    • 7.6 Russia

    8 Asia-Pacific

    • 8.1 Asia-Pacific Solid Formulations Drug Delivery Market Size by Region (2017-2028)
    • 8.2 China
    • 8.3 Japan
    • 8.4 South Korea
    • 8.5 India
    • 8.6 Australia
    • 8.7 China Taiwan
    • 8.8 Indonesia

    9 Latin America

    • 9.1 Latin America Solid Formulations Drug Delivery Market Size by Country (2017-2028)
    • 9.2 Mexico
    • 9.3 Brazil
    • 9.4 Argentina

    10 Middle East & Africa

    • 10.1 Middle East & Africa Solid Formulations Drug Delivery Market Size by Country (2017-2028)
    • 10.2 Turkey
    • 10.3 Saudi Arabia
    • 10.4 UAE

    11 Solid Formulations Drug Delivery Market Dynamics

    • 11.1 Solid Formulations Drug Delivery Industry Trends
    • 11.2 Solid Formulations Drug Delivery Market Drivers
    • 11.3 Solid Formulations Drug Delivery Market Challenges
    • 11.4 Solid Formulations Drug Delivery Market Restraints

    12 Research Finding /Conclusion

      13 Methodology and Data Source

      • 13.1 Methodology/Research Approach
      • 13.1.1 Research Programs/Design
    • 13.1.2 Market Size Estimation
    • 13.1.3 Market Breakdown and Data Triangulation
    • 13.2 Data Source
    • 13.2.1 Secondary Sources
    • 13.2.2 Primary Sources
    • 13.3 Disclaimer
    • Solid Formulations are a solid body drug delivery system of various weights and shapes, adapted for introduction into orifices of the human body.4 The external membrane of the suppository will typically melt, soften, or dissolve at body temperature which allows the active ingredient to then be absorbed by the surrounding tissue. Suppository bases usually employed are cocoa butter, glycerinated gelatin, hydrogenated vegetable oils, mixtures of polyethylene glycols of various molecular weights, and fatty acid esters of polyethylene glycol. The suppository base employed has a marked influence on the release of the active ingredient incorporated in it.
      Market Insights

      The research report studies the Solid Formulations Drug Delivery market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.

      Due to the COVID-19 pandemic, the global Solid Formulations Drug Delivery market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028.

      The global main companies of Solid Formulations Drug Delivery include Pfizer, Teva Pharmaceuticals, Bristol Myers Squibb, Lead Chemical, Purdue Pharma, Glenmark Pharmaceuticals, Galderma, Johnson & Johnson Private and GlaxoSmithKline, etc. In 2021, the global six largest players have a share approximately % in terms of revenue.

      The North America Solid Formulations Drug Delivery market is estimated at US$ million in 2021, while China is forecast to reach US$ million by 2028. The proportion of the China is % in 2021 and it is predicted that the share will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. As for the Europe Solid Formulations Drug Delivery landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

      Powders accounting for % of the Solid Formulations Drug Delivery global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Home Care Settings segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.

      Segment Scope

      An intensive study of key type and application segments has been done in this segmentation section. The authors of the report have provided reliable figures including revenue forecast data by type and application for the period 2017-2028. They have also studied how the segments are gaining or losing growth in various geographies and their respective countries. Thanks to this study, readers can thoroughly grasp the growth pattern and potential of different segments.

      Segment by Type

      Powders

      Suppositories

      Segment by Application

      Home Care Settings

      Hospitals & Clinics

      Burn Centers

      Other Facilities

      Regional Scope

      This segment of the report offers a thorough regional study of the global Solid Formulations Drug Delivery market. Drivers and restraints for each region are broadly examined in the report. Readers will get familiar with the driving forces and challenges that are specific to the regions. The specialists have identified growth opportunities in key geographical regions and their respective countries to aid players to reinforce their presence. All the regions and their countries in the report are assessed based on the growth rate and revenue according to the consumption for the period 2017-2028. This geographical analysis will help readers to gain in-depth knowledge of the regional growth. The key geographical regions surveyed in this research report involve North America, Europe, Asia Pacific, Central and South America, and Middle East and Africa. The report has specifically covered major countries including United States, Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.

      Key Players

      This section has provided an exhaustive analysis of the strategies that the companies are focusing on to stay ahead of other players. The strategies mainly involve research and development, new product developments, and mergers and acquisitions. The researchers have also provided revenue shares of the key companies, company overview, and the latest company developments so as to help players to sustain the cutthroat competition. In this section, the report offers global revenue data of manufacturers for the period 2017-2022. Following is the list of key manufacturers observed in this research study:

      Pfizer

      Teva Pharmaceuticals

      Bristol Myers Squibb

      Lead Chemical

      Purdue Pharma

      Glenmark Pharmaceuticals

      Galderma

      Johnson & Johnson Private

      GlaxoSmithKline

      Bausch Health Companies

      Hisamitsu Pharmaceuticals

      Cipla

      Bayer

      Viatris

      3M

      Merck & Co

      Crescita Therpeautics

      Novartis International

      Boehringer Ingelheim

      Frequently Asked Questions

      Which application segment captured the leading share in the Solid Formulations Drug Delivery market?

      How fragmented is the Solid Formulations Drug Delivery market?

      Which are the key growth drivers in the Solid Formulations Drug Delivery market?

      Which are the top strategies undertaken by the Solid Formulations Drug Delivery market players?

      Which technological trends are likely to affect the Solid Formulations Drug Delivery market?

      What is the expected Solid Formulations Drug Delivery market size by 2028?

      Which companies are dominating the Solid Formulations Drug Delivery market?

      Which region is projected to witness the fastest growth in the future?

      What factors are restraining the Solid Formulations Drug Delivery market growth?

      Which are the emerging companies in the Solid Formulations Drug Delivery market?

      Buy now